Search research articles
Contact Us
Filters
Showing results (221-230 of 293) with videos related to
Page
of 30
Sort By:
Seminars in Oncology
|
September 2, 2022
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans
Harshraj Leuva, Mengxi Zhou, Norbert Brau, et al.
Head & Neck
|
June 28, 2020
Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck
Rocco M Ferrandino, Scott Roof, Jonathan Garneau, et al.
JAMA Network Open
|
November 4, 2025
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Harshraj Leuva, Mengxi Zhou, Benjamin A Teply, et al.
Leukemia & Lymphoma
|
August 31, 2017
Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy
Madeleine Duvic, Susan E Bates, Richard Piekarz, et al.
Cancer Research
|
September 20, 2006
Autoantibody cancer biomarker: extracellular protein kinase A
Maria V Nesterova, Natalie Johnson, Christopher Cheadle, et al.
The Oncologist
|
April 14, 2021
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure
Christina A Del Guzzo, Arsenije Kojadinovic, Ravi R Vinnakota, et al.
Seminars in Oncology
|
June 27, 2024
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer
Harshraj Leuva, George Moran, Nader Jamaleddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine
Jame Abraham, Maureen Edgerly, Richard Wilson, et al.
Journal of Surgical Oncology
|
September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
Alexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Oncology Reports
|
January 17, 2009
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Zhi Shi, Smitaben Parmar, Xing-Xiang Peng, et al.
Page
of 30
Search research articles
Search
Showing results (221-230 of 293) with videos related to
Sort By:
Page
of 30
Seminars in Oncology
|
September 2, 2022
Influence of Cancer on COVID-19 Incidence, Outcomes, and Vaccine Effectiveness: A Prospective Cohort Study of U.S. Veterans
Harshraj Leuva, Mengxi Zhou, Norbert Brau, et al.
Head & Neck
|
June 28, 2020
Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck
Rocco M Ferrandino, Scott Roof, Jonathan Garneau, et al.
JAMA Network Open
|
November 4, 2025
Abiraterone vs Enzalutamide Among US Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Harshraj Leuva, Mengxi Zhou, Benjamin A Teply, et al.
Leukemia & Lymphoma
|
August 31, 2017
Responses to romidepsin in patients with cutaneous T-cell lymphoma and prior treatment with systemic chemotherapy
Madeleine Duvic, Susan E Bates, Richard Piekarz, et al.
Cancer Research
|
September 20, 2006
Autoantibody cancer biomarker: extracellular protein kinase A
Maria V Nesterova, Natalie Johnson, Christopher Cheadle, et al.
The Oncologist
|
April 14, 2021
Antibiotics and Imiquimod for Cutaneous T-Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure
Christina A Del Guzzo, Arsenije Kojadinovic, Ravi R Vinnakota, et al.
Seminars in Oncology
|
June 27, 2024
Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer
Harshraj Leuva, George Moran, Nader Jamaleddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine
Jame Abraham, Maureen Edgerly, Richard Wilson, et al.
Journal of Surgical Oncology
|
September 1, 2022
Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer
Alexander S Thomas, Wooil Kwon, David P Horowitz, et al.
Oncology Reports
|
January 17, 2009
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Zhi Shi, Smitaben Parmar, Xing-Xiang Peng, et al.
Page
of 30